Skip to main content
. Author manuscript; available in PMC: 2020 Jul 28.
Published in final edited form as: J Thorac Oncol. 2019 Aug 6;14(12):2181–2187. doi: 10.1016/j.jtho.2019.07.020

Table 1.

Patient characteristics. DM= Patients with a diagnosis of Diabetes Mellitus not on metformin. FEV1 = Forced expiratory volume in first second. DLCO = Diffusion capacity of lung to carbon monoxide. Adeno = adenocarcinoma. SqCC = Squamous cell carcinoma. BMI = Body mass index. ASA = American Society for Anesthesiology score.

Characteristic Non-diabetic DM Metformin P-Value

N 325 35 74
Mean Age 66 69 72 <0.05
Female (%) 210 (65%) 23(66%) 37 (50%) 0.06
Race
White 295 (91%) 30 (86%) 64 (86%) 0.13
Black  22 (7%)  3 (9%) 10(14%)
Other  8 (2%)  2 (6%)  0 (0%)
FEV1 %pred (mean) 82% 83% 83% NS
DLCO%pred (mean) 77% 71% 78% NS
Tumor grade
I/II 222 (68%) 21 (60%) 51 (68%) 0.59
III/IV 103 (32%) 14 (40%) 23 (32%)
Smoking status 0.27
Current  92 (28.3%) 9 (25.7%) 14 (18.9%)
Former 132 (40.6%) 21 (60.0%) 38 (51.4%)
Never  27 (8.3%)  3 (8.6%)  8 (10.8%)
Quit 49 (15.1%) 0 (0%) 9 (12.2%)
Recent quit 24 (7.4%) 2(5.7%) 5 (6.8%)
Unknown  1 (0.3%)
Histology
Adeno 243 (75%) 23 (66%) 47 (64%) 0.1
SqCC  82 (25%) 12 (34%) 27 (36%)
BMI (mean) 26.9 30.3 31.4 <0.05
ASA
2 184 (57%) 11 (31%) 22 (30%) <0.01
3 138 (42%) 24 (69%) 52 (70%)
4  3 (1%)  0 (0%)  0 (0%)
BMI ≥25 209 (64%) 29 (83%) 66 (89%) <0.01
BMI ≥30 69 (21%) 15 (43%) 37 (50%) <0.01